Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites

Protein Expression and Purification

Volumn 34, Issue 2, 2004, Pages 284-295

  Gårdsvoll, Henrik ^a   Werner, Finn ^b   Søndergaard, Leif ^c   Danø, Keld ^a   Ploug, Michael ^a  

^a FINSEN LABORATORY   (Denmark)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

CHO cells; Drosophila S2 cells; Insect cell expression; N glycosylation; Site directed mutagenesis; uPAR; Urokinase receptor

Indexed keywords

CRICETINAE; CRICETULUS GRISEUS; DROSOPHILA; INSECTA;

EID: 12144288162     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2003.12.002     Document Type: Article

References (42)

1. J. Rømer, T.H. Bugge, C. Pyke, L.R. Lund, M.J. Flick, J.L. Degen, K. Danø, Impaired wound healing in mice with a disrupted plasminogen gene, Nat. Med. 2 (1996) 287-292.
2. K. Danø, J. Rømer, B.S. Nielsen, S. Bjørn, C. Pyke, J. Rygaard, L.R. Lund, Cancer invasion and tissue remodeling-cooperation of protease systems and cell types, APMIS 107 (1999) 120-127.
3. P.A. Andreasen, R. Egelund, H.H. Petersen, The plasminogen activation system in tumor growth, invasion, and metastasis, Cell. Mol. Life Sci. 57 (2000) 25-40.
4. M. Ploug, E. Rønne, N. Behrendt, A.L. Jensen, F. Blasi, K. Danø, Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl- phosphatidylinositol, J. Biol. Chem. 266 (1991) 1926-1933.
5. M. Ploug, Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor, Curr. Pharm. Des. 9 (2003) 1499-1528.
6. L. Kjøller, The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility, Biol. Chem. 383 (2002) 5-19.
7. F. Blasi, P. Carmeliet, uPAR: a versatile signalling orchestrator, Nat. Rev. Mol. Cell Biol. 3 (2002) 932-943.
8. A.L. Roldan, M.V. Cubellis, M.T. Masucci, N. Behrendt, L.R. Lund, K. Danø, E. Appella, F. Blasi, Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis, EMBO J. 9 (1990) 467-174.
9. L.B. Møller, M. Ploug, F. Blasi, Structural requirements for glycosyl-phosphatidyl-inositol-anchor attachment in the cellular receptor for urokinase plasminogen activator, Eur. J. Biochem. 208 (1992) 493-500.
10. 2-terminal amino acid sequence and variants, J. Biol. Chem. 265 (1990) 6453-6460.
11. L.R. Lund, V. Ellis, E. Rønne, C. Pyke, K. Danø, Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549, Biochem. J. 310 (1995) 252-345.
12. M. Ploug, V. Ellis, Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins, FEBS Lett. 349 (1994) 163-168.
13. D. Servant, A. Ménez, Snake neurotoxins that interact with nicotinic acetylcholine receptors, in: E.J. Massaro (Ed.), Handbook of Neurotoxicology, vol. 1, Humana Press, Totowa, NJ, 2001, pp. 385-425.
14. V. Magdolen, P. Rettenberger, M. Koppitz, L. Goretzki, H. Kessler, U.H. Weidle, B. Konig, H. Graeff, M. Schmidt, O. Wilhelm, Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator, Eur. J. Biochem. 237 (1996) 743-751.
15. M. Ploug, S. Østergaard, B.B. Hansen, A. Holm, K. Danø, Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist. Evidence for a composite ligand-binding site and a short interdomain separation, Biochemistry 37 (1998) 3612-3622.
16. M. Ploug, V. Ellis, K. Danø, Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor, Biochemistry 33 (1994) 8991-8997.
17. N. Behrendt, E. Rønne, K. Danø, Domain interplay in the urokinase receptor. Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains, J. Biol. Chem. 271 (1996) 22885-22894.
18. H. Gårdsvoll, K. Danø, M. Ploug, Mapping part of the functional epitope for ligand binding on the human receptor for urokinase-type plasminogen activator by site-directed mutagenesis, J. Biol. Chem. 274 (1999) 37995-38003.
19. T.H. Bugge, L.R. Lund, K.K. Kombrinck, B.S. Nielsen, K. Holmbäck, A.F. Drew, M.J. Flick, D.P. Witte, K. Danø, J. Degen, Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen- deficient mice, Oncogene 16 (1998) 3097-3104.
20. M. Ploug, S. Østergård, H. Gårdsvoll, A. Holm, C. Holst-Hansen, L. Ossowski, K. Danø, Peptide derived antagonists of the urokinase receptor. Affinity maturation by combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation, Biochemistry 40 (2001) 12157-12168.
21. H. Pedersen, N. Brünner, D. Francis, K. Østerlind, E. Rønne, H.H. Hansen, K. Danø, J. Grøndahl-Hansen, Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer, Cancer Res. 54 (1994) 4671-4675.
22. J. Grøndahl-Hansen, H.A. Peters, W.L. van Putten, M.P. Look, H. Pappot, E. Rønne, K. Danø, J.G.M. Klijn, N. Brünner, J.A. Foekens, Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer, Clin. Cancer Res. 1 (1995) 1079-1087.
23. J.H. De Witte, J.A. Foekens, N. Brünner, J.J. Heuvel, T. van Tienoven, M.P. Look, J.G. Klijn, A. Geurts-Moespot, N. Grebenchtchikov, T. Benraad, C.G. Sweep, Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours, Br. J. Cancer 6 (2001) 85-92.
24. S. Memarzedeh, K.R. Kozak, L. Chang, S. Natarajan, P. Shintaku, S.T. Reddy, R. Farias-Eisner, Urokinase plasminogen activator receptor: prognostic biomarker for endometrial cancer, Proc. Natl. Acad. Sci. USA 99 (2002) 10647-10652.
25. R.W. Stephens, H.J. Nielsen, I.J. Christensen, O. Thorlacius-Ussing, K. Danø, N. Brünner, Plasma urokinase receptor in colorectal cancer patients: relation to prognosis, J. Natl. Cancer Inst. 91 (1999) 869-874.
26. M.T. Masucci, N. Pedersen, F. Blasi, A soluble, ligand binding mutant of the human plasminogen activator receptor, J. Biol. Chem. 66 (1991) 8655-8658.
27. E. Rønne, N. Behrendt, M. Ploug, H.J. Nielsen, E. Wollisch, U. Weidle, K. Danø, G. Høyer-Hansen, Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay, J. Immunol. Methods 167 (1991) 91-101.
28. M. Ploug, H. Rahbek-Nielsen, P.F. Nielsen, P. Roepstorff, K. Danø, Glycosylation profile of a recombinant urokinase receptor expressed in chinese hamster ovary cells, J. Biol. Chem. 273 (1998) 13933-13943.
29. 12 is important for cell surface expression, FEBS Lett. 486 (2000) 320-324.
30. V. Picard, E. Ersdal-Badju, A. Lu, S.C. Bock, A rapid and efficient one-tube PCR-based mutagenesis technique using Pfu DNA polymerase, Nucleic Acids Res. 22 (1994) 2587-2591.
31. E. Rønne, G. Høyer-Hansen, N. Brünner, H. Pedersen, F. Rank, C.K. Osborne, G.M. Clark, K. Danø, J. Grøndahl-Hansen, Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono-and polyclonal antibodies, Breast Cancer Res. Treat. 33 (1995) 199-207.
32. K. Josephson, D.T. McPherson, M.R. Walter, Purification, crystallization and preliminary X-ray diffraction of a complex between IL-10 and soluble IL-10R1, Acta Crystallogr. D 57 (2001) 1908-1911.
33. M. Ploug, M. Kjalke, E. Rønne, U. Weidle, G. Høyer-Hansen, K. Danø, Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins, J. Biol. Chem. 268 (1993) 17539-17546.
34. P.M. Rudd, M.R. Wormald, R.L. Stanfield, M. Huang, N. Mattsson, J.A. Speir, J.A. DiGennaro, J.S. Fetrow, R.A. Dwek, I.A. Wilson, Roles for glycosylation of cell surface receptors involved in cellular immune recognition, J. Mol. Biol. 293 (1999) 351-366.
35. W.A. Hendrickson, Production of crystallizable fragments of membrane proteins, J. Bioenerg. Biomembr. 28 (1996) 35-40.
36. L.B. Møller, J. Pöllänen, E. Roønne, N. Pedersen, F. Blasi, N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand, J. Biol. Chem. 268 (1993) 11152-11159.
37. I. Nilsson, G. von Heijne, Glycosylation efficiency of Asn-Xaa-Thr sequons depends both on the distance from the C-terminus and on the presence of a downstream transmembrane segment, J. Biol. Chem. 275 (2000) 17338-17343.
38. A.R. Walmsley, N.M. Hooper, Distance of sequons to the C-terminus influences the cellular N-glycosylation of the prion protein, Biochem. J. 370 (2003) 351-355.
39. A. Újvári, R. Aron, T. Eisenhaure, E. Chen, H.A. Parag, Y. Smicun, R. Halaban, D.N. Hebert, Translation rate of human tyrosinase determines its N-linked glycosylation level, J. Biol. Chem. 276 (2001) 5924-5931.
40. K. Bdeir, A. Kuo, A. Mazar, B.S. Sachais, W. Xiao, S. Gawlak, S. Harris, A.A.-R. Higazi, D.B. Cines, A region in domain II of the urokinase receptor required for urokinase binding, J. Biol. Chem. 275 (2000) 28532-28538.
41. T. Tarui, A.P. Mazar, D.B. Cines, Y. Takada, Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction, J. Biol. Chem. 276 (2001) 3983-3990.
42. J.M.H. van den Elsen, D.A. Kuntz, D.R. Rose, Structure of golgi α-mannosidase II: a target for inhibition of growth and metastasis of cancer cells, EMBO J. 20 (2001) 3008-3017.